MedTrace Logo

Trevo® Retriever Registry Post Market Surveillance

NCT02040259 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2008

Last updated 2020-06-24

Study results available
· View outcomes & findings →

Summary

The purpose of the Trevo® Retriever Registry is to collect real world performance data of the Trevo Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.

Conditions

Sponsors & Collaborators

  • Stryker Neurovascular

    lead INDUSTRY

Principal Investigators

  • Erol Veznedaroglu, MD · Drexel Neurosciences Institute,Philadelphia

  • Ronald Budzik, MD · Riverside Methodist Hospital/ Ohio Health Research Institute, Columbus, OH

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-25
Primary Completion
2017-12-28
Completion
2017-12-28

Countries

  • United States
  • Canada
  • Czechia
  • France
  • Germany
  • Hungary
  • Italy
  • Singapore
  • South Korea
  • Spain
  • Switzerland
  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02040259 on ClinicalTrials.gov